Torsten Hechler

HDP-101, an Anti-BCMA Antibody–Drug Conjugate, Safely Delivers Amanitin to Induce Cell Death in Proliferating and Resting Multiple Myeloma Cells

Vianihuini Figueroa-Vazquez, Jonathan Ko, Christian Breunig et al. · Molecular Cancer Therapeutics · 2020 · 78 citations · Full text

Medicine, Oncology, Pharmacology +13

CRISPR-based screens uncover determinants of immunotherapy response in multiple myeloma

Poornima Ramkumar, Anthony Abarientos, Ruilin Tian et al. · Blood Advances · 2020 · 60 citations · Full text

Medicine, Immunology, Oncology +17

AGR2-Dependent Nuclear Import of RNA Polymerase II Constitutes a Specific Target of Pancreatic Ductal Adenocarcinoma in the Context of Wild-Type p53

Zhiheng Zhang, Hongzhen Li, Yibin Deng et al. · Gastroenterology · 2021 · 41 citations · Full text

Medicine, Molecular Biology, Oncology +15

RETRACTED: Targeted immunotherapy for HER2-low breast cancer with 17p loss

Yujing Li, Yifan Sun, Michael Kulke et al. · Science Translational Medicine · 2021 · 34 citations · Full text

Medicine, Cancer Biology, Oncology +16

Synthesis and biological evaluation of RGD and isoDGR peptidomimetic-α-amanitin conjugates for tumor-targeting

Lizeth Bodero, P. López, Bárbara Korsak et al. · Beilstein Journal of Organic Chemistry · 2018 · 33 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17